Questions a plan sponsor actually asks.
What is Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine and Amphetamine used for?
Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine and Amphetamine is a this drug class medication tracked in Medicare Part D.
Is there a generic for Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine and Amphetamine?
Yes. 192 ANDAs filed at FDA, 22 generic manufacturers currently shipping.
How much does my plan pay for Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine and Amphetamine?
Across 329 Part D plans, Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine and Amphetamine averages $0.278/unit (NADAC). Lowest available: $0.239/unit. Highest in distribution: $0.314/unit.
Is Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine and Amphetamine on the FDA shortage list?
Yes. Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine and Amphetamine is currently listed as an active FDA shortage.
2 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (6 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.